Literature DB >> 3679422

Mutagenicity and carcinogenicity of masheri, a pyrolysed tobacco product, and its content of tobacco-specific nitrosamines.

S V Bhide1, J Kulkarni, U J Nair, B Spiegelhalder, R Preussmann.   

Abstract

Masheri, an indigenous pyrolysed tobacco product in India, was studied for its chemical, mutagenic and carcinogenic profile. Masheri extract was found to be rich in N-nitrosamines and polycyclic aromatic hydrocarbons. It was highly mutagenic in the presence of an exogenous metabolic system in the Ames test and in the micronucleus test, in a dose-dependent manner. It also induced 8-azaguanine-resistant mutants in Chinese hamster V79 cells. On skin painting, it showed a weak carcinogenic effect in Swiss nude mice. The saliva of masheri users showed high levels of N'-nitrosonornicotine (NNN; 14-43 ppb) and N-nitrosopyrrolidine (NPYR; 2.2-8.3 ppb). Thus, this widespread habit, predominant among women, could be an additive risk factor in the high incidence of oropharyngeal cancer prevalent in India.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3679422

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  4 in total

1.  Daily lifestyles and anti-mutagenicity of saliva.

Authors:  Masahiro Toda; Kanehisa Morimoto; Sei-Ichi Nakamura; Kazuo Hayakawa
Journal:  Environ Health Prev Med       Date:  2002-04       Impact factor: 3.674

2.  The unique correlation between anti-mutagenicity of human saliva and change in body weight.

Authors:  M Toda; K Morimoto; S Nakamura; T Umeda; S Nakaji; K Sugawara
Journal:  Environ Health Prev Med       Date:  2001-07       Impact factor: 3.674

3.  Carcinogenicity of Indian bidi and cigarette smoke condensate in Swiss albino mice.

Authors:  S S Pakhale; S Sarkar; K Jayant; S V Bhide
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

4.  Relationship between type of smokeless tobacco & risk of cancer: A systematic review.

Authors:  Sanjay Gupta; Ruchika Gupta; Dhirendra N Sinha; Ravi Mehrotra
Journal:  Indian J Med Res       Date:  2018-07       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.